Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingvild Birschmann

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Thrombosis and Haemostasis|November 9, 2010
ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus depositionClemens L Bockmeyer, Phillipp A Reuken, Tim P Simon, et al.
Thrombosis and Haemostasis|December 7, 2017
Diagnostic Accuracy of a Novel Chromogenic Direct Thrombin Inhibitor Assay: Clinical Experiences for Dabigatran MonitoringSven Poli, Florian Härtig, Charlotte Spencer, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 20, 2026
Acquired Factor XIII Deficiency in Critical Care: Registry-Based Analysis of Features, Symptoms and Risk FactorsMichael Hetz, Michaela Wilhelmi, Lutz Mirow, et al.
Thrombosis and Haemostasis|January 20, 2021
Specific Point-of-Care Testing of Coagulation in Patients Treated with DabigatranFlorian Härtig, Ingvild Birschmann, Andreas Peter, et al.
Stroke|August 15, 2015
Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral AnticoagulantsMatthias Ebner, Andreas Peter, Charlotte Spencer, et al.
Journal of Thrombosis and Thrombolysis|May 22, 2020
Point-of-care testing of coagulation in patients treated with edoxabanFlorian Härtig, Ingvild Birschmann, Andreas Peter, et al.
Critical Care (London, England)|March 25, 2022
The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healingChristian Kleber, Armin Sablotzki, Sebastian Casu, et al.
Neurological Research and Practice|March 1, 2021
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxabanFlorian Härtig, Ingvild Birschmann, Andreas Peter, et al.
Neurological Research and Practice|May 1, 2022
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registryWaltraud Pfeilschifter, Edelgard Lindhoff-Last, Ali Alhashim, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA RegistryJana Last, Ingvild Birschmann, Simone Lindau, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|November 9, 2010
ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus depositionClemens L Bockmeyer, Phillipp A Reuken, Tim P Simon, et al.
Thrombosis and Haemostasis|December 7, 2017
Diagnostic Accuracy of a Novel Chromogenic Direct Thrombin Inhibitor Assay: Clinical Experiences for Dabigatran MonitoringSven Poli, Florian Härtig, Charlotte Spencer, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 20, 2026
Acquired Factor XIII Deficiency in Critical Care: Registry-Based Analysis of Features, Symptoms and Risk FactorsMichael Hetz, Michaela Wilhelmi, Lutz Mirow, et al.
Thrombosis and Haemostasis|January 20, 2021
Specific Point-of-Care Testing of Coagulation in Patients Treated with DabigatranFlorian Härtig, Ingvild Birschmann, Andreas Peter, et al.
Stroke|August 15, 2015
Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral AnticoagulantsMatthias Ebner, Andreas Peter, Charlotte Spencer, et al.
Journal of Thrombosis and Thrombolysis|May 22, 2020
Point-of-care testing of coagulation in patients treated with edoxabanFlorian Härtig, Ingvild Birschmann, Andreas Peter, et al.
Critical Care (London, England)|March 25, 2022
The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healingChristian Kleber, Armin Sablotzki, Sebastian Casu, et al.
Neurological Research and Practice|March 1, 2021
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxabanFlorian Härtig, Ingvild Birschmann, Andreas Peter, et al.
Neurological Research and Practice|May 1, 2022
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registryWaltraud Pfeilschifter, Edelgard Lindhoff-Last, Ali Alhashim, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA RegistryJana Last, Ingvild Birschmann, Simone Lindau, et al.
Pageof 7